Ichor (ICHR) Tops Q3 EPS by 2c, Offers Q4 Guidance

Ichor (NASDAQ: ICHR) reported Q3 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $227.7 million versus the consensus estimate of $225.28 million.

GUIDANCE:

Ichor sees Q4 2020 EPS of $0.59-$0.77, versus the consensus of $0.64. Ichor sees Q4 2020 revenue of $220-245 million, versus the consensus of $228.4 million.

For earnings history and earnings-related data on Ichor (ICHR) click here.

You May Also Be Interested In

• 908 Devices Inc. (MASS) Misses Q2 EPS by 17c ; Offers Guidance
• Neurogene (NGNE) Tops Q2 EPS by 38c
• Bicara Therapeutics Inc. (BCAX) Reports Q2 Loss of $0.82